{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:52:47Z","timestamp":1791204767282,"version":"4.1.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003193","name":"Ministry of Education Science Research and Sport of the Slovak Republic","doi-asserted-by":"publisher","award":["KEGA 024UPJ\\u0160-4\/2024"],"award-info":[{"award-number":["KEGA 024UPJ\\u0160-4\/2024"]}],"id":[{"id":"10.13039\/501100003193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003193","name":"Ministry of Education Science Research and Sport of the Slovak Republic","doi-asserted-by":"publisher","award":["VEGA 1 \/0500\/23"],"award-info":[{"award-number":["VEGA 1 \/0500\/23"]}],"id":[{"id":"10.13039\/501100003193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.advms.2026.07.002","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:30:25Z","timestamp":1785281425000},"page":"269-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epitranscriptomic regulation in the progression of cancer and platinum resistance"],"prefix":"10.1016","volume":"71","author":[{"given":"Pavol","family":"Harvanik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ter\u00e9zia","family":"Hud\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"\u0160emel\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Sol\u00e1rov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1287-2979","authenticated-orcid":false,"given":"Peter","family":"Sol\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2026.07.002_bib1","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1039\/D0SC04082G","article-title":"Metallodrugs are unique: opportunities and challenges of discovery and development","volume":"11","author":"Anthony","year":"2020","journal-title":"Chem Sci"},{"key":"10.1016\/j.advms.2026.07.002_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1021\/acs.chemrev.8b00685","article-title":"Introduction: metals in medicine","volume":"119","author":"Franz","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.advms.2026.07.002_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5603\/NJO.a2022.0011","article-title":"Selected platinum complexes in standard and modern anti-cancer therapies","volume":"72","author":"Kopacz-Bednarska","year":"2022","journal-title":"Nowotwory"},{"key":"10.1016\/j.advms.2026.07.002_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143384","article-title":"Mitochondrial involvement in cisplatin resistance","volume":"20","author":"Cocetta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.advms.2026.07.002_bib5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: past, present and future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.advms.2026.07.002_bib6","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.advms.2026.07.002_bib7","article-title":"The drug-resistance mechanisms of five platinum-based Antitumor Agents","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.advms.2026.07.002_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.msec.2018.10.092","article-title":"Delivery of platinum (II) drugs with bulky ligands in trans-geometry for overcoming cisplatin drug resistance","volume":"96","author":"Yang","year":"2019","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.advms.2026.07.002_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-025-02812-3","article-title":"Advances in platinum-based cancer therapy: overcoming platinum resistance through rational combinatorial strategies","volume":"42","author":"Yusoh","year":"2025","journal-title":"Med Oncol"},{"key":"10.1016\/j.advms.2026.07.002_bib10","article-title":"The targeted therapies for Osteosarcoma via six major pathways","volume":"17","author":"Wang","year":"2024","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.advms.2026.07.002_bib11","article-title":"Ultrasound-Triggered Cascade delivery via poly-oxaliplatin nanoparticles for immunotherapy","volume":"35","author":"Shen","year":"2025","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.advms.2026.07.002_bib12","article-title":"Engineered metal and their complexes for nanomedicine-elicited cancer immunotherapy","volume":"15","author":"Wang","year":"2022","journal-title":"Mater Today Adv"},{"key":"10.1016\/j.advms.2026.07.002_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/0109298665292042240325052536","article-title":"Guanidinium-based integrated peptide dendrimers: pioneer nanocarrier in cancer therapy","volume":"31","author":"Singh","year":"2024","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.advms.2026.07.002_bib14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.advms.2026.07.002_bib15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","article-title":"Dynamic RNA modifications in gene expression regulation","volume":"169","author":"Roundtree","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.advms.2026.07.002_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100937","article-title":"Exosomal circular RNAs: a chief culprit in cancer chemotherapy resistance","volume":"67","author":"Guo","year":"2023","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.advms.2026.07.002_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","article-title":"The role of m6A methylation in therapy resistance in cancer","volume":"22","author":"Zhuang","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.advms.2026.07.002_bib18","first-page":"S185","article-title":"Epitranscriptomic regulations in the heart","volume":"73","author":"Benak","year":"2024","journal-title":"Physiol Res"},{"key":"10.1016\/j.advms.2026.07.002_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2025.106037","article-title":"Epitranscriptomic dysregulation in neurodegenerative diseases and its implications for disease pathology and mechanisms","volume":"190","author":"Shafik","year":"2025","journal-title":"Neurochem Int"},{"key":"10.1016\/j.advms.2026.07.002_bib20","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/s41380-022-01570-2","article-title":"Epitranscriptomic dynamics in brain development and disease","volume":"27","author":"Shafik","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.advms.2026.07.002_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-024-01854-w","article-title":"Decoding the epitranscriptome: a new frontier for cancer therapy and drug resistance","volume":"22","author":"Tang","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.advms.2026.07.002_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177397","article-title":"Pharmacology of epitranscriptomic modifications: decoding the therapeutic potential of RNA modifications in drug resistance","volume":"994","author":"Alkhammash","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.advms.2026.07.002_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-025-10419-0","article-title":"Modifications of RNA in cancer: a comprehensive review","volume":"52","author":"Ranga","year":"2025","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.advms.2026.07.002_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1537861","article-title":"RNA modifications and their role in gene expression","volume":"12","author":"Artika","year":"2025","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.advms.2026.07.002_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02089-6","article-title":"Writers, readers, and erasers RNA modifications and drug resistance in cancer","volume":"23","author":"Chen","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.advms.2026.07.002_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40164-022-00298-7","article-title":"Role of m6A writers, erasers and readers in cancer","volume":"11","author":"Fang","year":"2022","journal-title":"Exp Hematol Oncol"},{"issue":"6","key":"10.1016\/j.advms.2026.07.002_bib27","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res"},{"key":"10.1016\/j.advms.2026.07.002_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.advms.2026.07.002_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","article-title":"The epitranscriptome beyond m6A","volume":"22","author":"Wiener","year":"2021","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.advms.2026.07.002_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/b106365","article-title":"The biosynthesis and functional roles of methylated nucleosides in eukaryotic mRNA","volume":"12","author":"Bokar","year":"2005","journal-title":"Top Curr Genet"},{"key":"10.1016\/j.advms.2026.07.002_bib31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tig.2017.04.003","article-title":"m6A in mRNA: an Ancient mechanism for fine-tuning gene expression","volume":"33","author":"Roignant","year":"2017","journal-title":"Trends Genet"},{"key":"10.1016\/j.advms.2026.07.002_bib32","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1080\/15476286.2016.1201628","article-title":"m6A: signaling for mRNA splicing","volume":"13","author":"Adhikari","year":"2016","journal-title":"RNA Biol"},{"key":"10.1016\/j.advms.2026.07.002_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00085","article-title":"Epitranscriptomics: a new regulatory mechanism of brain development and function","volume":"12","author":"Noack","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.advms.2026.07.002_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01263-w","article-title":"The role of m6A, m5C and \u03a8 RNA modifications in cancer: novel therapeutic opportunities","volume":"20","author":"Nombela","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.advms.2026.07.002_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-016-0395-8","article-title":"Emerging links between m6A and misregulated mRNA methylation in cancer","volume":"9","author":"Jaffrey","year":"2017","journal-title":"Genome Med"},{"key":"10.1016\/j.advms.2026.07.002_bib36","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.18632\/oncotarget.23554","article-title":"Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer","volume":"9","author":"Nishizawa","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.advms.2026.07.002_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.advms.2026.07.002_bib38","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.advms.2026.07.002_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.advms.2026.07.002_bib40","article-title":"Genetic alterations of m6A regulators predict poorer survival in acute myeloid leukemia","volume":"10","author":"Kwok","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.advms.2026.07.002_bib41","first-page":"621","article-title":"The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells","volume":"52","author":"Taketo","year":"2018","journal-title":"Int J Oncol"},{"key":"10.1016\/j.advms.2026.07.002_bib42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/iub.2410","article-title":"m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK\/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation","volume":"73","author":"Ma","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.advms.2026.07.002_bib43","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.13571","article-title":"Targeting protein kinase CK2 suppresses bladder cancer cell survival via the glucose metabolic pathway","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.advms.2026.07.002_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.omtn.2020.10.031","article-title":"ALKBH5 inhibited cell proliferation and sensitized bladder cancer cells to Cisplatin by m6A-CK2\u03b1-Mediated glycolysis","volume":"23","author":"Yu","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.advms.2026.07.002_bib45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10495-020-01591-8","article-title":"DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG","volume":"25","author":"Shriwas","year":"2020","journal-title":"Apoptosis"},{"key":"10.1016\/j.advms.2026.07.002_bib46","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/kjm2.12902","article-title":"IGF2BP3-dependent N6-methyladenosine modification of USP49 promotes carboplatin resistance in retinoblastoma by enhancing autophagy via regulating the stabilization of SIRT1","volume":"40","author":"Li","year":"2024","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.advms.2026.07.002_bib47","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.7150\/ijbs.97425","article-title":"Targeting METTL3 enhances the chemosensitivity of non-small cell lung cancer cells by decreasing ABCC2 expression in an m6A-YTHDF1-dependent manner","volume":"20","author":"Zhang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.advms.2026.07.002_bib48","article-title":"N 6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance","volume":"9","author":"Lin","year":"2022","journal-title":"Milit Med Res"},{"key":"10.1016\/j.advms.2026.07.002_bib49","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1021\/acs.molpharmaceut.0c00961","article-title":"Tumor-Associated macrophages promote oxaliplatin resistance via METTL3-Mediated m6A of TRAF5 and necroptosis in colorectal cancer","volume":"18","author":"Lan","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.advms.2026.07.002_bib50","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04129-0","article-title":"METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability","volume":"79","author":"Li","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.advms.2026.07.002_bib51","article-title":"METTL3 confers oxaliplatin resistance through the activation of G6PD-enhanced pentose phosphate pathway in hepatocellular carcinoma","author":"Jin","year":"2024","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.advms.2026.07.002_bib52","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-024-03134-4","article-title":"m6A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma","volume":"43","author":"Lin","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.advms.2026.07.002_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217254","article-title":"WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis","volume":"604","author":"Tan","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.advms.2026.07.002_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01917-5","article-title":"N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation","volume":"23","author":"Li","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.advms.2026.07.002_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2023.11.034","article-title":"m6A-modified RIPK4 facilitates proliferation and cisplatin resistance in epithelial ovarian cancer","volume":"180","author":"Yin","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.advms.2026.07.002_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/1535-7163.MCT-22-0278","article-title":"N6-Methyladenosine RNA modifications regulate the response to platinum through nicotinamide N-methyltransferase","volume":"22","author":"Huang","year":"2023","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.advms.2026.07.002_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115484","article-title":"PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms","volume":"44","author":"Xia","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.advms.2026.07.002_bib58","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2809199","article-title":"N6-methyladenosine methyltransferase METTL3 enhances PTGER2 expression to increase ovarian cancer stemness and chemoresistance","volume":"28","author":"Lin","year":"2023","journal-title":"Frontiers in Bioscience - Landmark"},{"key":"10.1016\/j.advms.2026.07.002_bib59","article-title":"ALKBH5 regulates ovarian cancer growth via demethylating long noncoding RNA PVT1 in ovarian cancer","volume":"28","author":"Li","year":"2024","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.advms.2026.07.002_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24761","article-title":"METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K\/AKT pathway","volume":"36","author":"Cui","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.advms.2026.07.002_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111698","article-title":"FTO triggers NLRP3\/GSDMD-dependent pyroptosis to enhance cisplatin-sensitivity in ovarian cancer","volume":"131","author":"Zhang","year":"2025","journal-title":"Cell Signal"},{"key":"10.1016\/j.advms.2026.07.002_bib62","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s10495-025-02094-0","article-title":"YTHDF1-mediated m6A modification promotes cisplatin resistance in ovarian cancer via the FZD7\/Wnt\/\u03b2-catenin pathway","volume":"30","author":"Miao","year":"2025","journal-title":"Apoptosis"},{"key":"10.1016\/j.advms.2026.07.002_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118878","article-title":"m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells","volume":"1868","author":"Hao","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.advms.2026.07.002_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2025.138854","article-title":"Fine particulate matter exacerbates asthma by activating STC2-mediated mitophagy through METTL3\/YTHDF2-dependent m6A methylation","volume":"495","author":"Liu","year":"2025","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.advms.2026.07.002_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1683819","article-title":"METTL3-driven m6A modification orchestrates mitophagy-dependent ferroptosis in PM2.5-induced lung injury","volume":"16","author":"Ran","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.advms.2026.07.002_bib66","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.devcel.2022.05.007","article-title":"PDGF signaling inhibits mitophagy in glioblastoma stem cells through N6-methyladenosine","volume":"57","author":"Lv","year":"2022","journal-title":"Dev Cell"},{"key":"10.1016\/j.advms.2026.07.002_bib67","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1080\/15548627.2022.2114765","article-title":"Growth factor receptor signaling induces mitophagy through epitranscriptomic regulation","volume":"19","author":"Lv","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.advms.2026.07.002_bib68","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02638-9","article-title":"METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy","volume":"42","author":"Sun","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.advms.2026.07.002_bib69","doi-asserted-by":"crossref","DOI":"10.21037\/tau-20-1411","article-title":"The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma","volume":"10","author":"Chen","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.advms.2026.07.002_bib70","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.7150\/ijbs.86719","article-title":"METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway","volume":"20","author":"Yu","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.advms.2026.07.002_bib71","article-title":"The impact of m6A RNA modification in therapy resistance of cancer: implication in chemotherapy, radiotherapy, and immunotherapy","volume":"10","author":"Shriwas","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.advms.2026.07.002_bib72","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1128-6","article-title":"M6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling","volume":"19","author":"Tang","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.advms.2026.07.002_bib73","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41397-019-0110-4","article-title":"Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer","volume":"20","author":"Meng","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.advms.2026.07.002_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-020-00510-w","article-title":"METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner","volume":"53","author":"Pan","year":"2021","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.advms.2026.07.002_bib75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13045-021-01129-8","article-title":"N6-methyladenosine methyltransferases: functions, regulation, and clinical potential","volume":"14","author":"Huang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.advms.2026.07.002_bib76","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/0113892029296712240405053201","article-title":"Ramifications of m6A modification on ncRNAs in cancer","volume":"25","author":"Mehmood","year":"2024","journal-title":"Curr Genom"},{"key":"10.1016\/j.advms.2026.07.002_bib77","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.tibs.2025.06.012","article-title":"The crosstalk of m6A-modified RNA with DNA damage repair","volume":"50","author":"Qu","year":"2025","journal-title":"Trends Biochem Sci"},{"issue":"10","key":"10.1016\/j.advms.2026.07.002_bib78","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41419-024-07148-w","article-title":"Autophagy: a critical mechanism of N6-methyladenosine modification involved in tumor progression and therapy resistance","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.advms.2026.07.002_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100720","article-title":"Surmounting cancer drug resistance: new insights from the perspective of N6-methyladenosine RNA modification","volume":"53","author":"Li","year":"2020","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.advms.2026.07.002_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118432","article-title":"RNA modifications in cancer: from biological insights to therapeutic targets","volume":"132","author":"Zhao","year":"2026","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.advms.2026.07.002_bib81","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2024.20","article-title":"Epitranscriptomics and cervical cancer: the emerging role of m6A, m5C and m1A RNA modifications","volume":"26","author":"Modi","year":"2024","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.advms.2026.07.002_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43556-023-00139-x","article-title":"RNA modification: mechanisms and therapeutic targets","volume":"4","author":"Qiu","year":"2023","journal-title":"Molecular Biomedicine"},{"key":"10.1016\/j.advms.2026.07.002_bib83","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nature16998","article-title":"The dynamic N1-methyladenosine methylome in eukaryotic messenger RNA","volume":"530","author":"Dominissini","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.advms.2026.07.002_bib84","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ymthe.2022.10.015","article-title":"N1-methyladenosine formation, gene regulation, biological functions, and clinical relevance","volume":"31","author":"Xiong","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.advms.2026.07.002_bib85","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1016\/j.csbj.2022.11.045","article-title":"N1-methyladenosine modification in cancer biology: current status and future perspectives","volume":"20","author":"Li","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.advms.2026.07.002_bib86","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/iub.2534","article-title":"N1-methyladenosine profiling of long non-coding RNA in colorectal cancer","volume":"73","author":"Shi","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.advms.2026.07.002_bib87","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12964-023-01401-z","article-title":"Research progress of N1-methyladenosine RNA modification in cancer","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.advms.2026.07.002_bib88","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/jgh.14117","article-title":"Association of AlkB homolog 3 expression with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma","volume":"33","author":"Wang","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.advms.2026.07.002_bib89","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbagrm.2018.10.008","article-title":"Human ALKBH3-induced m1A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells","volume":"1862","author":"Woo","year":"2019","journal-title":"Biochim Biophys Acta, Gene Regul Mech"},{"key":"10.1016\/j.advms.2026.07.002_bib90","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/sj.bjc.6606012","article-title":"ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer","volume":"104","author":"Tasaki","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.advms.2026.07.002_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1145766","article-title":"Epitranscriptomics in the development, functions, and disorders of cancer stem cells","volume":"13","author":"Hao","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.advms.2026.07.002_bib92","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12967-022-03427-2","article-title":"5-methylcytosine RNA methyltransferases and their potential roles in cancer","volume":"20","author":"Li","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.advms.2026.07.002_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1028","article-title":"Positive epigenetic regulation loop between AR and NSUN2 promotes prostate cancer progression","volume":"12","author":"Zhu","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.advms.2026.07.002_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217064","article-title":"YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modification","volume":"597","author":"Meng","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.advms.2026.07.002_bib95","article-title":"YB1 modulates the DNA damage response in medulloblastoma","volume":"13","author":"McSwain","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.advms.2026.07.002_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217494","article-title":"CircKIAA0182-YBX1 axis: a key driver of lung cancer progression and chemoresistance","volume":"612","author":"Huang","year":"2025","journal-title":"Cancer Lett"},{"key":"10.1016\/j.advms.2026.07.002_bib97","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1158\/1078-0432.CCR-22-0991","article-title":"CircIPO7 promotes nasopharyngeal carcinoma metastasis and Cisplatin chemoresistance by facilitating YBX1 nuclear localization","volume":"28","author":"Hong","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.advms.2026.07.002_bib98","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-024-03103-x","article-title":"lncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1","volume":"43","author":"Qin","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.advms.2026.07.002_bib99","article-title":"RNA 5-Methylcytosine regulators contribute to metabolism heterogeneity and predict prognosis in ovarian cancer","volume":"10","author":"Xu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.advms.2026.07.002_bib100","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/cam4.5018","article-title":"Genetic variants in RNA m5C modification genes associated with survival and chemotherapy efficacy of colorectal cancer","volume":"12","author":"Chen","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.advms.2026.07.002_bib101","article-title":"M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients","volume":"28","author":"Li","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.advms.2026.07.002_bib102","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41388-023-02882-5","article-title":"M7G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma","volume":"43","author":"He","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.advms.2026.07.002_bib103","doi-asserted-by":"crossref","first-page":"12328","DOI":"10.18632\/aging.102575","article-title":"Overexpressed methyltransferase-like 1 (METTL1) increased chemosensitivity of colon cancer cells to cisplatin by regulating miR-149-3p\/S100A4\/p53 axis","volume":"11","author":"Liu","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.advms.2026.07.002_bib104","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/s41388-022-02250-9","article-title":"N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT\/\u03b2-catenin pathway in nasopharyngeal carcinoma","volume":"41","author":"Chen","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.advms.2026.07.002_bib105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/nar\/gky1163","article-title":"Inosine induces context-dependent recoding and translational stalling","volume":"47","author":"Licht","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.advms.2026.07.002_bib106","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/gb-2012-13-12-252","article-title":"The ADAR protein family","volume":"13","author":"Savva","year":"2012","journal-title":"Genome Biol"},{"key":"10.1016\/j.advms.2026.07.002_bib107","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01465-x","article-title":"The role of ADAR1 through and beyond its editing activity in cancer","volume":"22","author":"Jiao","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.advms.2026.07.002_bib108","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.tig.2022.03.013","article-title":"ADAR1 and its implications in cancer development and treatment","volume":"38","author":"Baker","year":"2022","journal-title":"Trends Genet"},{"key":"10.1016\/j.advms.2026.07.002_bib109","article-title":"ADAR1-Mediated RNA editing and its role in cancer","volume":"10","author":"Liu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.advms.2026.07.002_bib110","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13659","article-title":"ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A-to-I editing manner","volume":"57","author":"Liu","year":"2024","journal-title":"Cell Prolif"},{"key":"10.1016\/j.advms.2026.07.002_bib111","first-page":"229","article-title":"The allelic expression of RNA editing gene ADARB1 in hepatocellular carcinoma treated with transarterial chemoembolization","volume":"16","author":"Zeng","year":"2023","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1016\/j.advms.2026.07.002_bib112","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/CAD.0000000000001516","article-title":"ADAR1 affects gastric cancer cell metastasis and reverses cisplatin resistance through AZIN1","volume":"34","author":"Wang","year":"2023","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.advms.2026.07.002_bib113","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38581-8","article-title":"ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer","volume":"14","author":"Wong","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.advms.2026.07.002_bib114","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s43018-025-00907-4","article-title":"Targeting ADAR1 with a small molecule for the treatment of prostate cancer","volume":"6","author":"Wang","year":"2025","journal-title":"Nat Cancer"},{"key":"10.1016\/j.advms.2026.07.002_bib115","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3390\/ijms18112387","article-title":"The dark side of the epitranscriptome: Chemical modifications in long non-coding RNAs","volume":"18","author":"Jacob","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.advms.2026.07.002_bib116","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.chembiol.2006.09.009","article-title":"Pseudouridine synthases","volume":"13","author":"Hamma","year":"2006","journal-title":"Chem Biol"},{"key":"10.1016\/j.advms.2026.07.002_bib117","article-title":"Multiomics and machine learning-based analysis of pancancer pseudouridine modifications","volume":"15","author":"Zhang","year":"2024","journal-title":"Discov Oncol"},{"key":"10.1016\/j.advms.2026.07.002_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-20167-7","article-title":"HSP90\/PUS7\/THUMPD1 promotes metastasis and cisplatin resistance in gastric cancer cells","volume":"15","author":"Ye","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.advms.2026.07.002_bib119","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-01003-0","article-title":"Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine","volume":"7","author":"Xue","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.advms.2026.07.002_bib120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.urolonc.2020.06.026","article-title":"Pseudouridine as a novel biomarker in prostate cancer","volume":"39","author":"Stockert","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.advms.2026.07.002_bib121","first-page":"262","article-title":"Predictive value of pseudouridine in prostate cancer","volume":"7","author":"Stockert","year":"2019","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/j.advms.2026.07.002_bib122","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.4580","article-title":"Dyskerin and TERC expression may condition survival in lung cancer patients","volume":"6","author":"Penzo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.advms.2026.07.002_bib123","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1126\/science.1079447","article-title":"Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification","volume":"299","author":"Ruggero","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.advms.2026.07.002_bib124","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1182\/blood-2007-04-083261","article-title":"A dyskerin motif reactivates telomerase activity in X-linked dyskeratosis congenita and in telomerase-deficient human cells","volume":"111","author":"Machado-Pinilla","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.advms.2026.07.002_bib125","doi-asserted-by":"crossref","first-page":"18114","DOI":"10.1021\/acs.jmedchem.5c01570","article-title":"Small-Molecule inhibitors targeting RNA m6A modifiers for cancer therapeutics: latest advances and future perspectives","volume":"68","author":"Tang","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.advms.2026.07.002_bib126","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1038\/s41375-025-02765-6","article-title":"Epitranscriptomic advances in normal and malignant hematopoiesis","volume":"39","author":"Eleftheriou","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.advms.2026.07.002_bib127","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/13543776.2024.2447056","article-title":"Patent landscape of small molecule inhibitors of METTL3 (2020-present)","volume":"35","author":"Wu","year":"2024","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.advms.2026.07.002_bib128","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00044-025-03464-8","article-title":"Discovery of CRBN-recruiting PROTAC degraders of the METTL3-METTL14 complex","volume":"34","author":"Smith","year":"2025","journal-title":"Med Chem Res"},{"key":"10.1016\/j.advms.2026.07.002_bib129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/jacsau.4c00040","article-title":"Proteolysis targeting chimera degraders of the METTL3-14 m6A-RNA methyltransferase","volume":"4","author":"Errani","year":"2024","journal-title":"JACS Au"},{"key":"10.1016\/j.advms.2026.07.002_bib130","doi-asserted-by":"crossref","first-page":"12738","DOI":"10.1021\/acs.jmedchem.1c00773","article-title":"1,4,9-Triazaspiro[5.5]undecan-2-one derivatives as potent and selective METTL3 inhibitors","volume":"64","author":"Dolbois","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.advms.2026.07.002_bib131","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.advms.2026.07.002_bib132","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.3390\/cimb45110555","article-title":"STM2457 inhibits the invasion and metastasis of pancreatic cancer by down-regulating BRAF-Activated noncoding RNA N6-Methyladenosine modification","volume":"45","author":"Hao","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.advms.2026.07.002_bib133","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi1782","article-title":"RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells","volume":"10","author":"Zhu","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.advms.2026.07.002_bib134","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.advms.2026.07.002_bib135","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","article-title":"R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m6A\/PFKP\/LDHB axis","volume":"81","author":"Qing","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.advms.2026.07.002_bib136","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG exhibits anti-tumor activity by targeting FTO\/m6A\/MYC\/CEBPA signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.advms.2026.07.002_bib137","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1039\/D1CB00075F","article-title":"Targeting the RNA demethylase FTO for cancer therapy","volume":"2","author":"Zhou","year":"2021","journal-title":"RSC Chem Biol"},{"key":"10.1016\/j.advms.2026.07.002_bib138","doi-asserted-by":"crossref","DOI":"10.1097\/CAD.0000000000001656","article-title":"Synergistic combination effect of the PCA-1\/ALKBH3 inhibitor HUHS015 on prostate cancer drugs in vitro and in vivo","volume":"36","author":"Mabuchi","year":"2025","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.advms.2026.07.002_bib139","doi-asserted-by":"crossref","first-page":"13452","DOI":"10.1039\/D4SC02943G","article-title":"In vitro selection of N 1-methyladenosine-sensitive RNA-cleaving deoxyribozymes with 105-fold selectivity over unmethylated RNA","volume":"15","author":"Shi","year":"2024","journal-title":"Chem Sci"},{"key":"10.1016\/j.advms.2026.07.002_bib140","first-page":"211","article-title":"Novel metabolically stable PCA-1\/ALKBH3 inhibitor has potent antiproliferative effects on DU145 cells in vivo","volume":"38","author":"Ueda","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.advms.2026.07.002_bib141","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bmcl.2014.01.008","article-title":"Design and synthesis of prostate cancer antigen-1 (PCA-1\/ALKBH3) inhibitors as anti-prostate cancer drugs","volume":"24","author":"Nakao","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.advms.2026.07.002_bib142","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nmeth.3453","article-title":"Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome","volume":"12","author":"Linder","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.advms.2026.07.002_bib143","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-63355-3","article-title":"Limits in the detection of m6A changes using MeRIP\/m6A-seq","volume":"10","author":"McIntyre","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.advms.2026.07.002_bib144","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.molcel.2021.12.038","article-title":"scDART-seq reveals distinct m6A signatures and mRNA methylation heterogeneity in single cells","volume":"82","author":"Tegowski","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.advms.2026.07.002_bib145","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20221680","article-title":"Spatial RNA sequencing methods show high resolution of single cell in cancer metastasis and the formation of tumor microenvironment","volume":"43","author":"Zheng","year":"2023","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1016\/j.advms.2026.07.002_bib146","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/s41467-022-30299-3","article-title":"Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell microniches","volume":"13","author":"Lee","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.advms.2026.07.002_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118432","article-title":"RNA modifications in cancer: from biological insights to therapeutic targets","volume":"132","author":"Zhao","year":"2026","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"10.1016\/j.advms.2026.07.002_bib148","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40364-025-00794-y","article-title":"RNA epigenetic modifications as dynamic biomarkers in cancer: from mechanisms to clinical translation","volume":"13","author":"Zhao","year":"2025","journal-title":"Biomarker Res"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112626000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112626000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:10:50Z","timestamp":1791202250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112626000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":148,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1896112626000313"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2026.07.002","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epitranscriptomic regulation in the progression of cancer and platinum resistance","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2026.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Medical University of Bialystok. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}